+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-12-22Number of Pages: 92

Cardiac Pacemaker Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Global Cardiac Pacemaker Market: Snapshot

By 2030, nearly 20% of the total U.S. population is expected to be made up of geriatrics, according to the U.S. Census Board. This is a huge growth in the number of elderly citizens in this country, and similar cases are being witnessed in most developed economies and a few developing ones as well. This rise in the geriatric population is expected to be the greatest driver for a lot of healthcare industry segments, including the market of cardiac pacemakers.

At the same time, the number of patients with heart complications is increasing significantly due to inculcation of modern lifestyles that can lead to obesity and high stress. Both factors are primarily responsible for the increasing demand for cardiac pacemakers among those younger than 65 years.

However, manufacturers of cardiac pacemakers also have to face problems such as the complex and time consuming approval procedure for sales of cardiac pacemakers due to their high risk nature of use. Additionally, players also have to significantly reduce their profit margins due to the implementation of policies such as the Affordable Healthcare Act in the U.S.

As a result of the given factors, the global revenue generated from cardiac pacemakers is expected to reach US$12.8 bn by the end of 2023, according to Transparency Market Research. In terms of volume, the total number of cardiac pacemakers consumed globally will cross 2.4 mn units.

cardiac-pacemaker-market"

 

Asia Pacific Shows High Growth Scope in Cardiac Pacemaker Demand

Based on the current trends in cardiac pacemaker supply and demand chains, Asia Pacific is expected to show the fastest growth rate, ending up with a share in volume of 20.3% by the end of 2023. The key factors responsible for the growth in cardiac pacemaker sales in this region include the growth in awareness of modern pacemakers and the increasing number of heart disease patients across the region.

Europe, however, is expected to retain its leading position for the number of cardiac pacemakers consumed. This region is expected to hold a volume share of 51.1% in 2023 due to a high percentage of the elderly and other heart disease patients. In terms of revenue, North America leads the global market for cardiac pacemakers.

Implantable Pacemakers Most Preferred Type Globally

Almost all of the cardiac pacemakers used in the world today are implantable as there are very few cases where external cardiac pacemakers would be required. Most patients with heart problems require implantable pacemakers. This segment is also expected to show the fastest growth rate for the coming few years due to a high global demand for advanced implantable cardiac pacemakers. The total revenue generated through implantable cardiac pacemakers is expected to reach US$12.5 bn by the end of 2023.

Most of the heart problem indicators point to the need for a permanent pacemaker. These include a complete atrio-ventricular blockage, symptomatic sinus bradycardia, and sick sinus syndrome. Sick sinus syndrome is additionally the most common illness faced by European patients in need of cardiac pacemakers.

The key companies in the cardiac pacemakers market include Medtronic, St. Jude Medical, Boston Scientific, Biotronik, and Sorin. A very small share of the cardiac pacemakers market is taken up by regional players, as the above leader constitute most of the global supply currently.


Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Global Cardiac Pacemakers Market– Industry Analysis
3.1 Introduction
3.2 Market Drivers
     3.2.1 Rise in Geriatric Population
     3.2.2 Increasing Worldwide Incidence of Cardiovascular Diseases
     3.2.3 Technological Advancements
3.3 Market Restraints
     3.3.1 Implementation of Affordable Healthcare Act
     3.3.2 Strict Regulatory Approval
     3.3.3 Rising Cost of Treatment
3.4 Opportunities
     3.4.1 High opportunities in emerging economies
     3.4.2 Emerging economies to offer sustained growth opportunities
3.5 Porter’s Five Force Analysis of the Global Cardiac Pacemakers Market
     3.5.1 Bargaining power of suppliers
     3.5.2 Bargaining power of buyers
     3.5.3 Threat of substitutes
     3.5.4 Threat of new entrants
     3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Cardiac Pacemakers Market, by Geography
3.7 Global Cardiac Pacemaker: Recalls and Replacement Trends
3.8 Competitive Landscape
     3.7.1 Market Share Analysis: Global Cardiac Pacemakers Market, 2014 (Value %)

Chapter 4 Global Cardiac Pacemakers Market, by Product Type
4.1 Global Cardiac Pacemaker Market Revenue, by product Type, 2013–2023, (US$ Mn)
4.2 Global Cardiac Pacemaker Market Revenue, By Product Type, 2013–2023 (Unit Volume)

Chapter 5 Global Implantable Cardiac Pacemakers Market, by Technology
5.1 Global Implantable Cardiac Pacemaker Market Revenue, By Technology, 2013–2023, (US$ Mn)
5.2 Global Implantable Cardiac Pacemaker Market Revenue, By Technology, 2013–2023, (Unit Volume)

Chapter 6 Global Cardiac Pacemakers Market, by Geography
6.1 Global Cardiac Pacemaker Market Revenue, by Geography, 2013 – 2023 (USD Mn)
6.2 Global Cardiac Pacemaker Market Revenue, by Geography, 2013 – 2023 (Volume Units)
6.3 North America Cardiac Pacemaker Market Revenue, 2013 - 2023, (USD Mn)
6.4 North America Cardiac Pacemaker Market Revenue, 2013 - 2023, (Volume Units)
6.5 Europe Cardiac Pacemaker Market Revenue, 2013 - 2023, (Volume Units)
6.6 Europe Cardiac Pacemaker Market Revenue, 2013 - 2023, (Volume Units)
6.7 Asia-Pacific Cardiac Pacemaker Market Revenue, 2013 - 2023, (US$ Mn)
6.8 Asia-Pacific Cardiac Pacemaker Market Revenue, 2013 - 2023, (Volume Units)
6.9 Rest of World Cardiac Pacemaker Market Revenue, 2013 - 2023, (US$ Mn)
6.10 Rest of World Cardiac Pacemaker Market Revenue, 2013 - 2023, (Volume Units)
6.11 North America Implantable Cardiac Pacemaker Market Revenue, 2013 - 2023, (US$ Mn)
6.12 North America Implantable Cardiac Pacemaker Market Revenue, 2013 - 2023, (Volume Units) 
6.13 Europe Implantable Cardiac Pacemaker Market Revenue, 2013 - 2023, (US$ Mn) 
6.14 Europe Implantable Cardiac Pacemaker Market Revenue, 2013 - 2023, (Volume Units)
6.15 Asia-Pacific Implantable Cardiac Pacemaker Market Revenue, 2013 - 2023, (US$ Mn)
6.16 Asia-Pacific Implantable Cardiac Pacemaker Market Revenue, 2013 - 2023, (Volume Units)
6.17 Rest of World Implantable Cardiac Pacemaker Market Revenue, 2013 - 2023, (US$ Mn)
6.18 Rest of World Implantable Cardiac Pacemaker Market Revenue, 2013 - 2023, (Volume Units)
6.19 North America Cardiac Pacemaker Market Revenue, by Country, 2013 – 2023 (US$ Mn)
6.20 North America Cardiac Pacemaker Market Revenue, by Country, 2013 – 2023 (Volume Units)
6.21 Europe Cardiac Pacemaker Market Revenue, by Country, 2013 – 2023 (US$ Mn)
6.22 Europe Cardiac Pacemaker Market Revenue, by Country, 2013 – 2023 (Volume Units) 
6.23 Asia Pacific Cardiac Pacemaker Market Revenue, by Country, 2013 – 2023 (US$ Mn) 
6.24 Asia Pacific Cardiac Pacemaker Market Revenue, by Country, 2013 – 2023 (Volume Units) 
6.25 Rest of World Cardiac Pacemaker Market Revenue, by Country, 2013 – 2023 (US$ Mn)
6.26 Rest of World Cardiac Pacemaker Market Revenue, by Country, 2013 – 2023 (Volume Units)

Chapter 7 Recommendations

Chapter 8 Company Profiles
8.1 BIOTRONIK SE & Co. KG
     8.1.1 Company Overview
     8.1.2 Product Portfolio
     8.1.3 Recent Developments
8.2 Boston Scientific Corporation
     8.2.1 Company Overview
     8.2.2 Financial Overview
     8.2.3 Product Portfolio
     8.2.4 Recent Developments
8.3 Cook Medical Inc.
     8.3.1 Company Profile
     8.3.3 Product Portfolio
     8.3.3 Recent Developments
8.4 MEDICO S.p.A.
     8.4.1 Company Overview
     8.4.2 Product Portfolio
     8.4.3 Recent Developments
8.5 Medtronic
     8.5.1 Company Overview
     8.5.2 Financial Overview
     8.5.3 Product Portfolio
     8.5.4 Recent Developments
8.6 SORIN S.p.A.
     8.6.1 Company Overview
     8.6.2 Financial Overview
     8.6.3 Product Portfolio
     8.6.4 Recent Developments
8.7 St. Jude Medical, Inc.
     8.7.1 Company Overview
     8.7.2 Financial Overview
     8.7.3 Product Portfolio
     8.7.4 Recent Developments

Cardiac pacemakers are battery-operated medical devices, when placed inside the chest or abdomen, helps controlling arrhythmia. It contains two parts: generator and leads. The battery contains leads and battery to control the heartbeat, while leads carry electrical signal to the heart. This report is on global cardiac pacemaker market which studies the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. This section also provides the overall information and data analysis of the global cardiac pacemaker market with respect to the leading market segments based on type of product, technology, and geography. 

The market overview section of the report includes qualitative analysis of the overall cardiac pacemaker market including the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five forces analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players has also been provided. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market. 

The global cardiac pacemakers market has been segmented on the basis of product type, technology, and geography. Based on product type, the cardiac pacemakers market has been categorized into two major segments: implantable and external. On the basis of technology, the global cardiac pacemakers market has been majorly segmented into three types: dual-chamber, single-chamber, and bi-ventricular. Market revenue in terms of USD million for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 are provided for all the segments, considering 2014 as the base year. 

Geographically, the cardiac pacemaker market has been categorized into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe comprises Germany, the U.K., and Rest of Europe. Asia-Pacific comprises China, India, and Rest of Asia-Pacific. Rest of World comprises of Latin America, Middle-East and Rest of World. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the cardiac pacemaker market. The report also profiles major players in the cardiac pacemaker market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Abbott Laboratories, Inc., BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cook Medical Inc., MEDICO S.p.A., Medtronic, SORIN Group., St. Jude Medical, Inc.  

The global Cardiac Pacemakers market is segmented as follows: 

Global Cardiac Pacemakers Market, by Product Type

  • Implantable Cardiac Pacemaker
  • External Cardiac Pacemaker 

Global Implantable Cardiac Pacemakers Market, by Technology

  • Dual-Pacemaker
  • Single-Chamber
  • Bi-Ventricular

Global Cardiac Pacemakers Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America
    • Middle-East
    • Africa 


 
 
Back To Top